Noramco
Noramco
Noramco
  • About Us
    • About Noramco
    • Our People
    • Leadership
    • Excellence in Compliance
    • Minimizing Risk
  • Products & Solutions
    • Active Pharmaceutical Ingredients
      • Active Pharmaceutical Ingredients
      • Nal Family of Antagonists
      • ADHD / Stimulants
      • Full Product List
    • Noramco Solutions
      • Noramco Solutions
      • Clinical Supply
      • Controlled Substance Building Blocks and Intermediates
    • Platform Technologies
      • Platform Technologies
      • Platform Technology: Custom Synthesis
    • Reference Standards
      • Reference Standards
      • Reference Standards: Custom Synthesis
    • Reference Standards Store
  • Careers
  • News & Events
    • News & Events
    • Press Releases
  • Contact

Sort by

  • Default sorting
  • Sort by popularity
  • Sort by newness
  • Sort by price: low to high
  • Sort by price: high to low

View

  • 9 items
  • 15 items
  • 30 items

Showing 1–9 of 18 results

  • 148_Oxymorphone-Base
    Quick ViewSelect options

    Oxymorphone Base (CII)

    $58.00 – $290.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 76-41-5 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0913-**
    Quick ViewSelect options
  • 132_Noroxymorphone-Base
    Quick ViewSelect options

    Noroxymorphone Base (CII)

    $350.00 – $1,400.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 33522-95-1 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-1022-**
    Quick ViewSelect options
  • 89_Oxycodone-HCl
    Quick ViewSelect options

    Oxycodone Hydrochloride (CII)

    $29.00 – $145.00
    <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 124-90-3</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-0102-**</p>
    Quick ViewSelect options
  • 88_Oxycodone-Base
    Quick ViewSelect options

    Oxycodone Base (CII)

    $232.00 – $1,160.00
    <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 76-42-6</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-0003-**</p>
    Quick ViewSelect options
  • 187_Pyran-Bridged-Oxymorphone-Dimer-HCl
    Quick ViewSelect options

    Pyran Bridged Oxymorphone Dimer HCl (CII)

    $575.00 – $2,300.00
    <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-2192-**</p>
    Quick ViewSelect options
  • 186_Oxymorphone-N-Oxide
    Quick ViewSelect options

    Oxymorphone N-Oxide (CII)

    $575.00 – $2,300.00
    <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 71360-37-7</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-1049-**</p>
    Quick ViewSelect options
  • 149_Oxymorphone-Hydrochloride
    Quick ViewSelect options

    Oxymorphone Hydrochloride (CII)

    $288.00 – $5,760.00
    <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 357-07-3</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-0095-**</p>
    Quick ViewSelect options
  • 183_Oxymorphone-Aldol-Dimer
    Quick ViewSelect options

    Oxymorphone Aldol Dimer (CII)

    $4,750.00 – $19,000.00
    <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-2133-**</p>
    Quick ViewSelect options
  • 178_8-Hydroxyoxymorphone-Base
    Quick ViewSelect options

    8-Hydroxyoxymorphone Base (CII)

    $719.00 – $2,876.00
    <p class="p1"><span style="color: #000000;"><strong>CAS#</strong></span> 109440-85-9</p> <p class="p1"><span style="color: #000000;"><strong>NDC#</strong></span> 51634-1050-**</p>
    Quick ViewSelect options
  • 1
  • 2

Recent Articles

  • Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech
  • Diversifying the Supply of Raw Materials
  • Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
  • Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
Copyright 2025 Noramco. All Rights Reserved. Contact | Legal Notice | Privacy Policy | Terms & Conditions | Benefits Transparency Mandate
  • About Us
    • About Noramco
    • Our People
    • Leadership
    • Excellence in Compliance
    • Minimizing Risk
  • Products & Solutions
    • Active Pharmaceutical Ingredients
      • Active Pharmaceutical Ingredients
      • Nal Family of Antagonists
      • ADHD / Stimulants
      • Full Product List
    • Noramco Solutions
      • Noramco Solutions
      • Clinical Supply
      • Controlled Substance Building Blocks and Intermediates
    • Platform Technologies
      • Platform Technologies
      • Platform Technology: Custom Synthesis
    • Reference Standards
      • Reference Standards
      • Reference Standards: Custom Synthesis
    • Reference Standards Store
  • Careers
  • News & Events
    • News & Events
    • Press Releases
  • Contact